Actavis to acquire Allergan for $66B

Actavis plc (NYSE:ACT) will acquire Allergan Inc. (NYSE:AGN) for $66 billion, or $219 per share. The price represents a 10% premium to Allergan's closing price of $198.65 on Nov. 14 before the deal was announced. Both companies' boards approved the deal, which is expected to close in 2Q15.

The deal gives Allergan shareholders $129.22 in cash and 0.3683 Actavis shares per Allergan share. Actavis President and CEO Brent Saunders will lead the combined company. ...